Articles

Steak n Shake hoping to roll out lower-cost, limited-service stores

TV spots for Steak n Shake Co. used to play up the chain’s full-service restaurants, complete with friendly servers, real plates
and glass ketchup bottles—a departure from the "workaraunts" operated by McDonald’s and Burger King. Now, Steak n Shake is developing plans for its own workaraunts.

Read More

With pharma famine looming, Lilly relying on snack-size deals

Compared with some of his pharmaceutical CEO peers these days, John Lechleiter has his company on a diet. Instead of using a mega-merger to bulk up before the famine that patent expirations will bring on the industry next year,
Lechleiter has Eli Lilly and Co. burning management fat while looking for smaller companies to munch on.

Read More

WellPoint to sell subsidiary for $4.6B

WellPoint Inc. has
agreed to sell its pharmacy benefits management arm for $4.675 billion in cash and stock to St. Louis-based Express Scripts,
the companies announced April 13.

Read More

Durham insider deal sparks outcry

Tim Durham is facing allegations of self-dealing after a publicly traded company he helps run in Dallas acquired assets from
a finance company he owns in Ohio.

Read More

Indy’s best leaders

Conseco has seen a string of leaders since the company began to stumble and co-founder Steve Hilbert stepped
down nearly nine years ago. The insurer still doesnâ??t have its footing, saying today its auditors arenâ??t

convinced it can

Read More

Ideal places for public companies

Just as an Indiana company goes through the nationâ??s first initial public offering in months, its executives
ratchet up their plans to move the headquarters out of state.

Mead Johnson, the Evansville baby formula maker, staged a successful IPO…

Read More

WellPoint brass and rank-and-file

WellPoint unwittingly made an interesting point this morning when it announced it expects to save $24 million
by laying off 600 workers.

Those 600 workers in affect are being valued at about half the $47.5 million in total compensation…

Read More

Lilly makes $6.5B acquisition

Eli Lilly and Co. CEO John Lechleiter played a game of pharmaceutical poker with former Lilly Chief Financial Officer Jim
Cornelius—and won.

Read More